STIM1 and neoplasm: In summary, our study revealed distinct but interrelated effects of SOCE in the progression of human prostate cancer and revealed that STIM1 and ORAI1 are expressed at lower levels in human prostate cancer cells than in normal tissues; in addition, the expression of these molecules is significantly decreased in tumor tissues that exhibit a low differentiation level.